These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25219749)

  • 1. Localized insulin-dependent amyloidosis with scar-tissue formation.
    Damm F; Goerdt S; Schmieder A
    J Am Acad Dermatol; 2014 Oct; 71(4):e160-2. PubMed ID: 25219749
    [No Abstract]   [Full Text] [Related]  

  • 2. Image Gallery: Amyloidoma secondary to insulin injection.
    John I
    Br J Dermatol; 2018 Sep; 179(3):e131. PubMed ID: 30222875
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of insulin injection sites: an unexpected finding of localized amyloidosis.
    Swift B
    Diabet Med; 2002 Oct; 19(10):881-2. PubMed ID: 12358880
    [No Abstract]   [Full Text] [Related]  

  • 4. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection.
    Kudo-Watanuki S; Kurihara E; Yamamoto K; Mukai K; Chen KR
    Clin Exp Dermatol; 2013 Jan; 38(1):25-9. PubMed ID: 22924529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodules of fibrocollagenous scar tissue induced by subcutaneous insulin injections: a cause of poor diabetic control.
    Wallymahmed ME; Littler P; Clegg C; Haqqani MT; Macfarlane IA
    Postgrad Med J; 2004 Dec; 80(950):732-3. PubMed ID: 15579616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
    Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
    Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
    [No Abstract]   [Full Text] [Related]  

  • 8. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
    Ansari AM; Osmani L; Matsangos AE; Li QK
    Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of lipohypertrophy in diabetes care.
    Hambridge K
    Br J Nurs; 2007 May 10-23; 16(9):520-4. PubMed ID: 17551441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate.
    D'Souza A; Theis JD; Vrana JA; Buadi F; Dispenzieri A; Dogan A
    Am J Hematol; 2012 Nov; 87(11):E131-2. PubMed ID: 23044893
    [No Abstract]   [Full Text] [Related]  

  • 11. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.
    Yumlu S; Barany R; Eriksson M; Röcken C
    Hum Pathol; 2009 Nov; 40(11):1655-60. PubMed ID: 19683329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastic lymphoma arising at the insulin injection sites in a child with type 1 diabetes mellitus.
    Wang JD; Chang TK; Shu SG
    J Pediatr; 2010 Dec; 157(6):1043-1043.e1. PubMed ID: 20547397
    [No Abstract]   [Full Text] [Related]  

  • 13. Localized cutaneous amyloid at an insulin injection site.
    Lonsdale-Eccles AA; Gonda P; Gilbertson JA; Haworth AE
    Clin Exp Dermatol; 2009 Dec; 34(8):e1027-8. PubMed ID: 20055830
    [No Abstract]   [Full Text] [Related]  

  • 14. [Insulin application techniques in adult patients with diabetes].
    Pelcl T; Prázný M
    Vnitr Lek; 2016; 62(6):486-90. PubMed ID: 27485848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous insulin-derived acanthosis nigricans: could it be a cause of increased insulin requirement?
    Dhingra M; Garg G; Gupta M; Khurana U; Thami GP
    Dermatol Online J; 2013 Jan; 19(1):9. PubMed ID: 23374951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of hypoglycemia by children with type 1 diabetes 6 to 11 years of age and their parents.
    Teuscher A; Fuller C
    Pediatrics; 2008 Dec; 122(6):1408-9; author reply 1409. PubMed ID: 19047266
    [No Abstract]   [Full Text] [Related]  

  • 18. [The treatment of type-1 diabetics with insulin-induced lipohypertrophy by liposuction].
    Hauner H; Olbrisch RR
    Dtsch Med Wochenschr; 1994 Mar; 119(12):414-7. PubMed ID: 8143555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
    Szypowska A; Skórka A; Pańkowska E
    Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Novel insulin products and delivery methods].
    Sipilä I; Saukkonen T
    Duodecim; 2004; 120(9):1167-72. PubMed ID: 15232860
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.